首頁 > 市場調查報告書 > 醫療設備

生技設備

市場調查報告書

商品編碼

1556456

歐洲生命科學工具與試劑市場

European Life Science Tools and Reagents Market

出版日期: 2024年09月11日 | 出版商:

BCC Research | 英文 128 Pages | 訂單完成後即時交付

價格

簡介目錄圖表

生命科學工具、試劑和 COVID-19 診斷產品的市場規模預計將從 2032 年的 147 億美元成長到 2024 年的 130 億美元，預測期內複合年成長率為 3.4%，到年終將達到154 億美元。

生命科學工具和試劑產業預計將從 2024 年的 125 億美元成長到 2029年終的153 億美元，複合年成長率為 4.2%。此外，生命科學COVID-19診斷產品領域預計將從2024年的4.796億美元成長到2029年終的2,940萬美元，複合年成長率為-42.8%。

本報告調查了歐洲生命科學工具和試劑市場，並提供了市場概況、市場影響因素和市場機會分析、法律制度、新興技術和技術發展趨勢、市場規模趨勢和預測以及各種細分。編譯詳細的區域分析、競爭格局、主要企業簡介等。

世界市場動態
市場促進因素
加大研發投入
慢性病增加
對不同診斷途徑和體外診斷的需求不斷增加
基因組和生物標記研究的成長
對個人化醫療的需求不斷增加
技術進步
市場限制因素
COVID-19 大流行結束
設備高成本
缺乏熟練人才
市場挑戰
監管障礙
市場機會
藥品法部分修改的正面影響
新技術

第4章新興科技與發展

概述
下一代療法
下一代診斷
數位化
人工智慧和機器學習
IoT
生命科學實驗室中的機器人

第5章市場區隔分析

概述
細分細分
歐洲生命科學工具與試劑市場：依產品類型
COVID-19 診斷測試市場
生命科學工具和試劑市場
歐洲生命科學工具與試劑市場：依應用分類
基因組學
蛋白質體學
細胞生物學/抗體/重組蛋白
幹細胞研究
影像工具和技術
動物模型
表觀遺傳學
代謝體學
其他
歐洲
英國
德國
法國
瑞士
西班牙
義大利
其他

第6章競爭訊息

PCR技術與試劑
抗體
酵素連結免疫吸附設備
ELISA套件和檢測
生命科學試劑套件和檢測
COVID-19 診斷
策略舉措
近期市場上推出的產品

第7章歐洲生命科學工具與試劑市場的永續性：ESG 視角

ESG：簡介
產業ESG實踐
ESG產業現狀
BCC的結語

第8章附錄

調查方法
縮寫詞
來源
公司簡介
AGILENT TECHNOLOGIES INC.
ALTONA DIAGNOSTICS GMBH
ANALYTIK JENA GMBH+CO. KG
BD
BIO-RAD LABORATORIES INC.
DANAHER CORP.
F. HOFFMANN-LA ROCHE LTD.
MERCK KGAA
PROMEGA CORP.
QIAGEN
REVVITY INC.
THERMO FISHER SCIENTIFIC INC.

簡介目錄圖表

Product Code: BIO262A

The European market for life science tools and reagents and COVID-19 diagnostics products was valued at $14.7 billion in 2023. The market is expected to grow from $13.0 billion in 2024 to $15.4 billion by the end of 2029, at a compound annual growth rate (CAGR) of 3.4% from 2024 through 2029.

The European market for life science tools and reagents is expected to grow from $12.5 billion in 2024 to $15.3 billion by the end of 2029, at a CAGR of 4.2% from 2024 through 2029.

The European market for life science COVID-19 diagnostics products is expected to decline from $479.6 million in 2024 to $29.4 million by the end of 2029, at a negative CAGR of 42.8% from 2024 through 2029.

Report Scope

This report provides a comprehensive analysis of the European market for life science tools and reagents, including the leading companies, their revenues, product portfolios and recent activities. It looks at the competitive landscape, trends and market dynamics, such as drivers, restraints and opportunities. It also analyzes the current and future markets. The reagents studied are antibodies, enzyme-linked immunosorbent assay (ELISA) kits, protein reagents and probes. The life science tools included are hybridization systems, PCR, Western blotting instruments and ELISA instruments. The countries whose markets are analyzed are Germany, France, the U.K., Italy, Spain, Switzerland and the Rest of Europe. Markets are also analyzed by application.

Report Includes

33 data tables and 54 additional tables
An analysis of the European market for life science tools and reagents, including COVID-19 diagnostics products
Analyses of the market trends, with historic market revenue data (sales figures) for 2021-2023, estimates for 2024, and projected CAGRs through 2029
Estimates of the market size and revenue forecasts for the market for life science tools and reagents, with market share analysis by product, application, and country
Discussions of the market dynamics, opportunities and challenges, as well as emerging technologies
Overview of the sustainability trends and ESG developments in the industry, with emphasis on the ESG practices of leading companies, their ESG scores, and consumer attitudes
Competitive intelligence, including companies' market shares, recent M&A activity and venture funding
Profiles of the leading companies, including Thermo Fisher Scientific Inc., Danaher Corp., Merck KGaA, Qiagen and Roche

Chapter 1 Executive Summary

Market Outlook
Scope of Report
Market Summary

Chapter 2 Market Overview

Overview
Product Development in Life Science

Chapter 3 Market Dynamics

Global Market Dynamics
Market Drivers
Increasing Investments in R&D
Increasing Prevalence of Chronic Diseases
Increasing Demand for Various Diagnostics Pathways and In Vitro Diagnostics
Growth in Genomic and Biomarker Research
Increasing Demand for Personalized Medicine
Technological Advances
Market Restraints
End of COVID-19 Pandemic
High Cost of Instruments
Lack of Skilled Personnels
Market Challenges
Regulatory Hurdles
Market Opportunities
Positive Impact from Some Revisions in Pharmaceutical Legislation
New Technologies

Chapter 4 Emerging Technologies and Developments

Overview
Next-Generation Therapeutics
Next-Generation Diagnostics
Digitalization
AI and Machine Learning
Internet of Things (IoT)
Robots in Life Science Labs

Chapter 5 Market Segmentation Analysis

Overview
Segmentation Breakdown
European Market for Life Science Tools and Diagnostics, by Product Type
COVID-19 Diagnostic Tests Market
Market for Life Science Tools and Reagents
European Market for Life Science Tools and Diagnostics, by Application
Genomics
Proteomics
Cell Biology, Antibodies and Recombinant Proteins
Stem Cells Research
Imaging Tools and Techniques
Animal Models
Epigenetics
Metabolomics
Other Applications
Europe
United Kingdom
Germany
France
Switzerland
Spain
Italy
Rest of Europe

Chapter 6 Competitive Intelligence

PCR Technologies and Reagents
Antibodies
ELISA Instruments
ELISA Kits and Assays
Life Science Kits and Assays
COVID-19 Diagnostics
Strategic Initiatives
Recent Product Introductions in the Market

Chapter 7 Sustainability in Life Science Tools and Reagents in the European Market: An ESG Perspective

Introduction to ESG
ESG Practices in the Industry
Status of ESG in the Industry
Concluding Remarks from BCC

Chapter 8 Appendix

Methodology
Acronyms
Sources
Company Profiles
AGILENT TECHNOLOGIES INC.
ALTONA DIAGNOSTICS GMBH
ANALYTIK JENA GMBH+CO. KG
BD
BIO-RAD LABORATORIES INC.
DANAHER CORP.
F. HOFFMANN-LA ROCHE LTD.
MERCK KGAA
PROMEGA CORP.
QIAGEN
REVVITY INC.
THERMO FISHER SCIENTIFIC INC.

簡介目錄圖表

List of Tables

Summary Table : European Market for Life Science Tools and COVID-19 Diagnostics, by Product Type, Through 2029
Table 1 : Differences Between Basic and Applied Research
Table 2 : Pharmaceutical Industry R&D Expenditures in Europe, by Select Countries, 2022
Table 3 : Cancer Cases in Europe for Both Sexes, 2022
Table 4 : European Market for Life Science Tools and COVID-19 Diagnostics, by Product Type, Through 2029
Table 5 : European Market for COVID-19 Diagnostics Tests, by Type, Through 2029
Table 6 : European Market for COVID-19 Molecular Tests, by Country, Through 2029
Table 7 : European Market for COVID-19 Antigen Tests, by Country, Through 2029
Table 8 : European Market for COVID-19 Serological Tests, by Country, Through 2029
Table 9 : European Market for Life Science Tools and Reagents, by Type, Through 2029
Table 10 : European Market for Life Science Instruments, by Country, Through 2029
Table 11 : European Market for Life Science Reagents and Kits, by Country, Through 2029
Table 12 : European Market for Life Science Tools and Reagents, by Application, Through 2029
Table 13 : European Market for Genomics, by Country, Through 2029
Table 14 : Drug Targets Identified by Proteomics
Table 15 : European Market for Proteomics, by Country, Through 2029
Table 16 : European Market for Cell Biology, Antibodies and Recombinant Proteins, by Country, Through 2029
Table 17 : European Market for Stem Cell Research, by Country, Through 2029
Table 18 : European Market for Imaging Tools and Techniques, by Country, Through 2029
Table 19 : European Market for Animal Models, by Country, Through 2029
Table 20 : European Market for Epigenetics, by Country, Through 2029
Table 21 : European Market for Metabolomics, by Country, Through 2029
Table 22 : European Market for Other Applications of Life Science Tools and Reagents, by Country, Through 2029
Table 23 : European Based Companies' R&D Expenditures and Comparison of Their Net Sales, 2023
Table 24 : European Market for Life Science Tools and Reagents, by Country, Through 2029
Table 25 : European Market for Life Science COVID-19 Diagnostics Tests, by Country, Through 2029
Table 26 : Ranking of Life Science Tool and Reagent Companies in Europe, 2023
Table 27 : Leading Providers of PCR Technologies, by Revenue, 2023
Table 28 : Leading Suppliers of Research Antibodies, 2023
Table 29 : Leading Providers of ELISA Instruments/Microplate Readers, 2023
Table 30 : Leading Providers of ELISA Kits and Assays, 2023
Table 31 : Ranking of Leading Suppliers of Kits and Assays, 2023
Table 32 : Ranking of Leading Providers of COVID-19 Diagnostics Tools, 2023
Table 33 : Collaborations in the Life Science Tools and Reagents Market, 2020-2024
Table 34 : Mergers and Acquisitions in the Life Science Tools and Reagents Market, 2021-2024
Table 35 : Recent New Life Science Tools and Reagents, 2021-2024
Table 36 : Key Focus Areas in ESG Metrics
Table 37 : Environmental Initiatives by Various Life Science Tools, Reagents and Diagnostics Companies and Some of their Initiatives in Europe
Table 38 : Key Social and Governance Issues in the Life Science Tools, Reagents and Diagnostics Industry
Table 39 : ESG Rankings for Companies in the Life Science Tools and Reagents Market, 2023
Table 40 : Glossary of Terms Used in This Report
Table 41 : Information Sources in This Report
Table 42 : Agilent Technologies Inc.: Company Snapshot
Table 43 : Agilent Technologies Inc.: Financial Performance, FY 2022 and 2023
Table 44 : Agilent Technologies Inc.: Product Portfolio
Table 45 : Agilent Technologies Inc.: News/Key Developments, 2023
Table 46 : Altona Diagnostic GmbH.: Company Snapshot
Table 47 : Altona Diagnostic GmbH: Product Portfolio
Table 48 : Altona Diagnostic GmbH: News/Key Developments, 2021-2023
Table 49 : Analytik Jena GmbH+Co KG: Company Snapshot
Table 50 : Analytik Jena GmbH+Co KG: Product Portfolio
Table 51 : Analytik Jena GmbH+Co KG: News/Key Developments, 2023
Table 52 : BD: Company Snapshot
Table 53 : BD: Financial Performance, FY 2022 and 2023
Table 54 : BD: Product Portfolio
Table 55 : BD: News/Key Developments, 2021-2024
Table 56 : Bio-Rad Laboratories Inc.: Company Snapshot
Table 57 : Bio-Rad Laboratories Inc.: Financial Performance, FY 2022 and 2023
Table 58 : Bio-Rad Laboratories Inc.: Product Portfolio
Table 59 : Bio-Rad Laboratories Inc.: News/Key Developments, 2022 and 2023
Table 60 : Danaher Corp.: Company Snapshot
Table 61 : Danaher Corp.: Financial Performance, FY 2022 and 2023
Table 62 : Danaher Corp.: Product Portfolio
Table 63 : Danaher Corp.: News/Key Developments, 2021-2023
Table 64 : F. Hoffmann-La Roche Ltd.: Company Snapshot
Table 65 : F. Hoffmann-La Roche Ltd.: Financial Performance, FY 2022 and 2023
Table 66 : F. Hoffmann-La Roche Ltd.: Product Portfolio
Table 67 : F. Hoffmann-La Roche Ltd.: News/Key Developments, 2021-2023
Table 68 : Merck KGaA: Company Snapshot
Table 69 : Merck KGaA: Financial Performance, FY 2022 and 2023
Table 70 : Merck KGaA.: Product Portfolio
Table 71 : Merck KGaA: News/Key Developments, 2021-2024
Table 72 : Promega Corp.: Company Snapshot
Table 73 : Promega Corp.: Product Portfolio
Table 74 : Promega Corp.: News/Key Developments, 2023 and 2024
Table 75 : Qiagen: Company Snapshot
Table 76 : Qiagen: Financial Performance, FY 2022 and 2023
Table 77 : Qiagen: Product Portfolio
Table 78 : Qiagen: News/Key Developments, 2023
Table 79 : Revvity Inc.: Company Snapshot
Table 80 : Revvity Inc.: Financial Performance, FY 2022 and 2023
Table 81 : Revvity Inc.: Product Portfolio
Table 82 : Revvity Inc.: News/Key Developments, 2023 and 2024
Table 83 : Thermo Fisher Scientific Inc.: Company Snapshot
Table 84 : Thermo Fisher Scientific Inc.: Financial Performance, FY 2022 and 2023
Table 85 : Thermo Fisher Scientific Inc.: Product Portfolio
Table 86 : Thermo Fisher Scientific Inc.: News/Key Developments, 2021-2024

List of Figures

Summary Figure : European Market for Life Science Tools and COVID-19 Diagnostics, by Product Type, 2021-2029
Figure 1 : Market Dynamics of European Life Science Tools and Reagents Market
Figure 2 : New Diagnostic Techniques
Figure 3 : Comparison of New Active Substances Approvals
Figure 4 : Comparison of European Patent Applications and Granted Patents, by Technical Field, 2011-2022
Figure 5 : European Market Shares of COVID-19 Diagnostics Tests, by Type, 2023
Figure 6 : European Market Shares of Life Science Tools and Reagents, by Type, 2023
Figure 7 : Types of ELISA
Figure 8 : Firms and R&D Investment in Health Industries, 2012 and 2022
Figure 9 : Pharmaceutical Pipeline Activity and Key Therapeutic Areas in Europe, 2022
Figure 10 : The U.K. Market for Life Science Tools and Reagents, 2024-2029
Figure 11 : German Market for Life Science Tools and Reagents, 2021-2029
Figure 12 : French Market for Life Science Tools and Reagents, 2021-2029
Figure 13 : Swiss Market for Life Science Tools and Reagents, 2024-2029
Figure 14 : Spanish Market for Life Science Tools and Reagents, 2024-2029
Figure 15 : Italian Market for Life Science Tools and Reagents, 2021-2029
Figure 16 : Rest of the European Market for Life Science Tools and Reagents, 2021-2029
Figure 17 : EPFIA's Environmental Sustainability Measures
Figure 18 : Agilent Technologies Inc.: Revenue Share, by Business Unit, FY 2023
Figure 19 : Agilent Technologies Inc.: Revenue Share, by Country/Region, FY 2023
Figure 20 : BD: Revenue Share, by Business Unit, FY 2023
Figure 21 : BD: Revenue Share, by Country/Region, FY 2023
Figure 22 : Bio-Rad Laboratories Inc.: Revenue Share, by Business Unit, FY 2023
Figure 23 : Bio-Rad Laboratories Inc.: Revenue Share, by Country/Region, FY 2023
Figure 24 : Danaher Corp.: Revenue Share, by Business Unit, FY 2023
Figure 25 : Danaher Corp.: Revenue Share, by Country/Region, FY 2023
Figure 26 : F. Hoffmann-La Roche Ltd.: Revenue Share, by Business Unit, FY 2023
Figure 27 : F. Hoffmann-La Roche Ltd.: Revenue Share, by Country/Region, FY 2023
Figure 28 : Merck KGaA: Revenue Share, by Business Unit, FY 2023
Figure 29 : Merck KGaA: Revenue Share, by Country/Region, FY 2023
Figure 30 : Qiagen: Revenue Share, by Business Unit, FY 2023
Figure 31 : Qiagen: Revenue Share, by Country/Region, FY 2023
Figure 32 : Revvity Inc.: Revenue Share, by Business Unit, FY 2023
Figure 33 : Revvity Inc.: Revenue Share, by Country/Region, FY 2023
Figure 34 : Thermo Fisher Scientific Inc.: Revenue Share, by Business Unit, FY 2023
Figure 35 : Thermo Fisher Scientific Inc.: Revenue Share, by Country/Region, FY 2023